The hepatic regeneration power of mild steatotic grafts is not impaired in living-donor liver transplantation

Liver Transplantation

Volumn 11, Issue 2, 2005, Pages 210-217

  Cho, Jai Young ^a   Suh, Kyung Suk ^a   Kwon, Choon Hyuck ^a   Yi, Nam Joon ^a   Cho, Soo Youn ^a   Jang, Ja June ^a   Kim, Se Hyung ^a   Lee, Kuhn Uk ^a  

^a Seoul National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLINE; KI 67 ANTIGEN; MONOCLONAL ANTIBODY KI 67;

ACUTE GRAFT REJECTION; ADULT; ARTERY OCCLUSION; ARTICLE; BILE DUCT ATRESIA; BILIARY TRACT DISEASE; CONTROLLED STUDY; DISEASE SEVERITY; FATTY LIVER; FEMALE; GRAFT DYSFUNCTION; HEPATIC ARTERY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTRAOPERATIVE PERIOD; LIVER BIOPSY; LIVER CELL; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FUNCTION; LIVER REGENERATION; LIVER TRANSPLANTATION; LIVING DONOR; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PNEUMONIA; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; SURGICAL RISK; TREATMENT OUTCOME;

ADULT; FATTY LIVER; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER; LIVER REGENERATION; LIVER TRANSPLANTATION; LIVING DONORS; MALE; MIDDLE AGED;

EID: 13944283869     PISSN: 15276465     EISSN: None     Source Type: Journal    
DOI: 10.1002/lt.20340     Document Type: Article

References (27)

1. Yoong KF, Gunson BK, Neil DA, Mirza DF, Mayer AD, Buckels JA, McMaster P. Impact of donor liver microvesicular steatosis on the outcome of liver retransplantation. Transplant Proc 1999;31:550-551.
2. Todo S, Demetris AJ, Makowka L, Teperman L, Podesta L, Shaver T, et al. Primary nonfunction of hepatic allografts with preexisting fatty infiltration. Transplantation 1989;47:903-905.
3. Ploeg RJ, D'Alessandro AM, Knechtle SJ, Stegall MD, Pirsch JD, Hoffmann RM, et al. Risk factors for primary dysfunction after liver transplantation - a multivariate analysis. Transplantation 1993;55:807-813.
4. Cheng YF, Chen CL, Lai CY, Chen TY, Huang TL, Lee TY, et al. Assessment of donor fatty livers for liver transplantation. Transplantation 2001;71:1221-1225.
5. Yoo HY, Molmenti E, Thuluvath PJ. The effect of donor body mass index on primary graft nonfunction, retransplantation rate, and early graft and patient survival after liver transplantation. Liver Transpl 2003;9:72-78.
6. Assy N, Minuk GY. Liver regeneration: methods for monitoring and their applications. J Hepatol 1997;26:945-952.
7. Gerlach C, Sakkab DY, Scholzen T, Dassler R, Alison MR, Gerdes J. Ki-67 expression during rat liver regeneration after partial hepatectomy. Hepatology 1997;26:573-578.
8. Yersiz H, Shaked A, Olthoff K, Imagawa D, Shackleton C, Martin P, Busuttil RW. Correlation between donor age and the pattern of liver graft recovery after transplantation. Transplantation 1995;60:790-794.
9. Kiuchi T, Kasahara M, Uryuhara K, Inomata Y, Uemoto S, Asonuma K, et al. Impact of graft size mismatching on graft prognosis in liver transplantation from living donors. Transplantation 1999;67:321-327.
10. Rinella ME, Alonso E, Rao S, Whitington P, Fryer J, Abecassis M, et al. Body mass index as a predictor of hepatic steatosis in living liver donors. Liver Transpl 2001;7:409-414.
11. Jacobs JE, Birnbaum BA, Shapiro MA, Langlotz CP, Slosman F, Rubesin SE, Horii SC. Diagnostic criteria for fatty infiltration of the liver on contrast-enhanced helical CT. Am J Roentgenol 1998;171:659-664.
12. Bellentani S, Saccoccio G, Masutti F, Croce LS, Brandi G, Sasso F, et al. Prevalence of and risk factors for hepatic steatosis in Northern Italy. Ann Intern Med 2000;132:112-117.
13. Urena MAG, Ruiz-Delgado FC, Gonzalez EM, Romero CJ, Farcia IG, Segurola CL, et al. Hepatic steatosis in liver transplant donors: common feature of donor population? World J Surg 1998;22:837-844.
14. Monsour HP Jr, Wood RP, Ozaki C, Katz S, Clark J, Dyer C, Camel S. Utility of preoperative liver biopsy in live-related donor patients for liver transplantation. Transplant Proc 1994;26:138-139.
15. Strasberg SM, Howard TK, Molmenti EP, Hertl M. Selecting the donor liver: risk factors for poor function after orthotopic liver transplantation. Hepatology 1994;20:829-838.
16. Adam R, Bismuth H, Diamond T, Ducot B, Morino M, Astarcioglu I, et al. Effect of extended cold ischaemia with UW solution on graft function after liver transplantation. Lancet 1992;340:1373-1376.
17. Soejima Y, Shimada M, Suehiro T, Kishikawa K, Yoshizumi T, Hashimoto K, et al. Use of steatotic graft in living-donor liver transplantation. Transplantation 2003;76:344-348.
18. Chui AK, Haghighi K, Painter D, Jayasundera M, Hall G, Rao AR, et al. Donor fatty (steatotic) liver allografts in orthotopic liver transplantation. Transplant Proc 1998;30:3286- 3287.
19. Hayashi M, Fujii K, Kiuchi T, Uryuhara K, Kasahara M, Takatsuki M, et al. Effects of fatty infiltration of the graft on the outcome of living-related liver transplantation. Transplant Proc 1999;31:403.
20. Friedman LS. The risk of surgery in patients with liver disease. Hepatology 1999;29:1617-1623.
21. Ricci C, Longo R, Gioulis E, Bosco M, Pollesllo P, Masutti F, et al. Noninvasive in vivo quantitative assessment of fat content in human liver. J Hepatol 1997;27:108-113.
22. Piekarski J, Goldberg HI, Royal SA, Axel L, Moss AA. Difference between liver and spleen CT numbers in the normal adult: its usefulness in predicting the presence of diffuse liver disease. Radiology 1980;137:727-729.
23. Limanond P, Raman SS, Lassman C, Sayre J, Ghobrial RM, Busuttil RW, et al. Macrovesicular hepatic steatosis in living related liver donors: correlation between CT and histologic findings. Radiology 2004;230:276-280.
24. Marcos A, Ham JM, Fisher RA, Olzinski AT, Posner MP. Single-center analysis of the first 40 adult-to-adult living donor liver transplants using the right lobe. Liver Transpl 2000;6:296-301.
25. Marcos A, Fisher RA, Ham JM, Shiffman ML, Sanyal AJ, Luketic VA, et al. Liver regeneration and function in donor and recipient after right lobe adult to adult living donor liver transplantation. Transplantation 2000;69:1375-1379.
26. Teramoto K, Bowers JL, Khettry U, Palombo JD, Clouse ME. A rat fatty liver transplant model. Transplantation 1993;55:737-741.
27. Marsman WA, Wiesner RH, Rodriguez L, Batts KP, Porayko MK, Hay JE, et al. Use of fatty donor liver is associated with diminished early patient and graft survival. Transplantation 1996;62:1246-1251.